CCG-63802


CAS No. : 620112-78-9

620112-78-9
Price and Availability of CAS No. : 620112-78-9
Size Price Stock
5mg $72 In-stock
10mg $120 In-stock
25mg $240 In-stock
50mg $390 In-stock
100mg $627 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-70074
M.Wt: 450.51
Formula: C26H18N4O2S
Purity: >98 %
Solubility: DMSO : 1.67 mg/mL (ultrasonic;warming)
Introduction of 620112-78-9 :

CCG-63802 is a selective, reversible and allosteric RGS4 inhibitor. CCG-63802 specifically binds to RGS4 and blocks the RGS4-Gαo interaction, with an IC50 value of 1.9 μM[1]. In Vitro: CCG-63802 (5 μM) inhibits regulators of G-protein signaling (RGS) proteins in the presence of BK (bradykinin) and 8-Br-cGMP (membrane-permeable analogue of cGMP), HEK-293 cells start to depolarize again[2]. In Vivo: CCG-63802 (0.05 mg/kg; intratracheal administration; once per week; 90 days) reduces RGS4 protein expression, leading to partially abrogate the attenuating effect of PGZ on airway inflammation, hyperresponsiveness (AHR), and remodeling[3].

Your information is safe with us.